Skip to main content

Update on CEO selection process

Amsterdam, 22 May 2026 Update on CEO selection process With Dolf van den Brink, HEINEKEN’s CEO and Chairman of the Executive Board, set to conclude his tenure on May 31, Peter Wennink, Chairman of the HEINEKEN Supervisory Board, commented on behalf of all colleagues: “I would like to thank Dolf for his 28 years of service to the Company, including the last six years as CEO. His contribution has been significant, and the Supervisory Board acknowledges with appreciation his strategic leadership and dedication.” Peter Wennink continued: “The selection process for Dolf’s successor is progressing well and is expected to be completed in the near term; up until then, any external commentary remains speculative. The Company’s EverGreen 2030 strategy is clear, and execution is accelerating in line with what was communicated at Full Year and Q1....

Continue reading

Form 8.3 – [ANIMALCARE GROUP PLC – 21 05 2026] – (CGWL)

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)   Full name of discloser: CANACCORD GENUITY WEALTH LIMITED (for Discretionary clients)(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A(c)   Name of offeror/offeree in relation to whose relevant securities this form relates:        Use a separate form for each offeror/offeree ANIMALCARE GROUP PLC(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A(e)   Date position...

Continue reading

WEMADE Gears Up for 2nd Global Esports Tournament, YMIR Cup World Championship

Season 2 of the live global esports event will take place at the SOOP Colosseum in Seoul from June 27–28 and will be livestreamed across major streaming platformsSEOUL, South Korea, May 22, 2026 (GLOBE NEWSWIRE) — WEMADE, the leading global game developer behind the blockbuster Unreal Engine 5 MMORPG Legend of YMIR, has announced that it will be hosting the YMIR Cup World Championship Season 2 from 27 to 28 June. Held live at the state-of-the-art SOOP Colosseum in Sangam, Seoul, this global esports tournament is designed to showcase the game’s high-level competitive depth and further establish the Norse mythology-inspired title as a premier global IP. Following the success of its inaugural tournament held in partnership with leading global gaming brand Razer in Singapore earlier this year, the YMIR Cup World Championship...

Continue reading

CSG and Reunert Establish Joint Venture to Manufacture Electronic Fuzes for Large-Calibre Ammunition

Industrial-technology group CSG and Reunert have entered into an agreement to establish a new business focused on the production of electronic fuzes for large-calibre ammunition in Slovakia to be named Fuchs Electronics Europe. The new business will be owned 51% by Reunert and 49% by CSG. Through its investment in Fuchs Electronics Europe, CSG will become one of the few manufacturers of electronic fuzes within the European Union. The project represents a significant step in further vertically integrating large-calibre ammunition production across CSG’s manufacturing base. It will expand the CSG’s technological capabilities to include a critical component of modern artillery ammunition, enhance competitiveness, and reinforce its position as a comprehensive supplier within European markets. Localising production within the European Union...

Continue reading

Notification on Apranga APB Chairman of the Board change

Apranga APB informs that at the meeting of the newly elected Board of the Company held on 20 May 2026, Vidas Lazickas was elected as the Chairman of the Board. Vidas Lazickas assumes the duties of the Chairman of the Board as of the date of this decision. He has been a member of the Board since 2011. Rimantas PerveneckasApranga Group General Director+370 5 2390801

Continue reading

Equans announces completion of the sale of its EV charging concessions in the Netherlands

PRESS RELEASE              Paris, 22 May 2026 Equans announces completion of the sale of its EV charging concessions in the Netherlands In line with the commitments it made at its Capital Markets Day 2023, Equans, a global leader in the Energy and Services sector and a subsidiary of the Bouygues Group, announces that it has completed, on May 18th, the sale of Equans Infra & Mobility (I&M), the entity holding its EV charging concessions in the Netherlands. The buyer of I&M is an entity controlled by DigitalBridge and Aberdeen Investments. They will continue to procure funding to accelerate the growth of the business in a rapidly evolving market environment. This divestment is part of Equans strategic plan, presented on February 23, 2023, at its Capital Markets Day, which includes the disposal of asset-based activities. As...

Continue reading

EXEL Industries: Half-year 2025–2026 results

Results for the first half of 2025–2026 Earnings were negatively impacted by lower volumes due to unfavorable market cycles. In this context, the Group has maintained its financing capacity and continues to reduce its net financial debt.In the first half of 2025–2026, EXEL Industries’s revenue fell 14.1% to €380.9 million. The Group is seeing its profitability levels decline, weighed down by the overall drop in volumes over the half-year. Half-year recurring EBITDA was negative, at -€7.2 million.The Group’s net financial debt improved to €167.8 million, compared with €174.5 million as of March 31, 2025. During the first half of the year, EXEL Industries continued to successfully renew its credit lines and maintained its financing capacity intact, despite challenging market conditions.H1 results(from October 1, 2025to March...

Continue reading

Richemont delivers strong sales growth and solid results for the year ended 31 March 2026

AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR22 MAY 2026 Please find below the Highlights and Chairman’s commentary from Richemont FY26 Annual Results Announcement. RICHEMONT DELIVERS STRONG SALES GROWTH AND SOLID RESULTSFOR THE YEAR ENDED 31 MARCH 2026 Group highlightsGroup sales at € 22.4 billion, up by 11% at constant rates (+5% actual) with continued momentum in Q4 at +13% Operating profit at € 4.5 billion including € 164 million of non-recurring costs, with strong top-line growth and cost discipline mitigating the effect of weaker main trading currencies and higher raw material costs Continued focus on cultivating Maisons’ long-term potential through sustained investment in craftsmanship, heritage preservation and strategic footprint expansion in distribution and manufacturingFinancial highlightsSales growth across all business...

Continue reading

Information relating to the total number of voting rights and share capital – April 30, 2026

   Disclosure of the total number of voting rights and shares, provided pursuant to article L. 233-8 II of the French Commercial Code and the Article 223-16 of the Règlement général de l’Autorité des marchés financiers   (Regulation of the French stock market authority) Company name of the issuer:         Renault S.A. 122 – 122 bis Avenue du Général Leclerc 92100 Boulogne-Billancourt (ISIN code: FR0000131906 – RNO)Date   Total number of issued shares     Total number of voting rightsApril 30, 2026     295,722,284     Theoretical number of voting rights(1): 405,532,284  Exercisable number of voting rights(2): 400,561,315(1)   Pursuant to Article 223-11 of the Règlement général de l’Autorité des marchés financiers, number calculated on the basis of all shares to which voting rights are attached, including shares for...

Continue reading

OSE Immunotherapeutics Reports Positive Topline Results of TEDOVA Phase 2 Trial with Tedopi® in Recurrent Ovarian Cancer

OSE Immunotherapeutics Reports Positive Topline Results of TEDOVA Phase 2 Trial with Tedopi® in Recurrent Ovarian CancerTopline results to be presented by Alexandra Leary, MD, PhD, on May 30, 2026, at the 2026 Annual Meeting of the American Society of Clinical Oncology (ASCO) in Chicago OSE Immunotherapeutics to host a KOL webcast on June 10, 2026Nantes, France, May 22, 2026 – 7:30am CET – OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE), a clinical-stage biotech company dedicated to developing first-in-class therapies in immuno-oncology and immuno-inflammation, today announced the release of the abstract selected for an oral presentation at the upcoming ASCO 2026Annual Meeting, unveiling topline results from the TEDOVA/GINECO-OV244b/ENGOT-ov58 academic, international, Phase 2 trial sponsored by ARCAGY-GINECO and evaluating...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.